von Willebrand factor genotyping for validation of type 2N von Willebrand disease subtitle: the relation between genotype and phenotype in von Willebrand disease type 2N

被引：0
|
作者：
Mancini, T. [1 ]
Van Haren, B. [1 ]
Schoormans, S. [1 ]
Hofste, T. [1 ]
Diekstra, A. [1 ]
Laros-van Gorkom, B. A. P. [1 ]
Brons, P. [1 ]
Hoefsloot, L. [1 ]
Van Heerde, W. L. [1 ]
机构：
[1] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：548 / 548
页数：1
相关论文
共 50 条
  • [41] Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype
    van Meegeren, M. E. R.
    Mancini, T. L.
    Schoormans, S. C. M.
    van Haren, B. J. T.
    van Duren, C.
    Diekstra, A.
    Laros-van Gorkom, B. A. P.
    Brons, P. P. T.
    Simons, A.
    Hoefsloot, L.
    van Heerde, W. L.
    HAEMOPHILIA, 2015, 21 (05) : E375 - E383
  • [42] The contribution of a reduced von Willebrand factor survival in type 2 von Willebrand disease
    Gallinaro, L.
    Cattini, M. G.
    Pontara, E.
    Sartorello, F.
    Daidone, V
    Padrini, R.
    Bertomoro, A.
    Pagnan, A.
    Casonato, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 843 - 843
  • [43] Combined hemophilia A and type 2N von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor
    Casonato, A
    Pontara, E
    Sartorello, F
    Gemmati, D
    Cattini, MG
    Girolami, A
    HAEMATOLOGICA, 2001, 86 (10) : 1110 - 1111
  • [44] Compound heterozygosity for type 2N and type 1 von Willebrand disease (VWD) associated with a homozygous-like type 2N VWD phenotype
    Chan, J
    Mitchell, MJ
    Brown, DA
    Bromidge, ES
    Williams, C
    Smith, MP
    Savidge, GF
    THROMBOSIS AND HAEMOSTASIS, 1999, : 558 - 558
  • [45] Type 2N von Willebrand disease due to Arg91Gln substitution and a cytosine deletion in exon 18 of the von Willebrand factor gene
    Casonato, A
    Gaucher, C
    Pontara, E
    Zucchetto, A
    Zerbinati, P
    Mazurier, C
    Girolami, A
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 103 (01) : 39 - 41
  • [46] von Willebrand factor alloantibodies in type 3 von Willebrand disease
    Kotnik, Barbara Faganel
    Strandberg, Karin
    Debeljak, Marusa
    Kitanovski, Lidija
    Jazbec, Janez
    Benedik-Dolnicar, Majda
    Bakija, Alenka Trampus
    BLOOD COAGULATION & FIBRINOLYSIS, 2020, 31 (01) : 77 - 79
  • [47] Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor
    Allen, S
    Abuzenadah, AM
    Blagg, JL
    Hinks, J
    Nesbitt, IM
    Goodeve, AC
    Gursel, T
    Ingerslev, J
    Peake, IR
    Daly, ME
    BLOOD, 2000, 95 (06) : 2000 - 2007
  • [48] von Willebrand disease phenotype and von Willebrand factor marker genotype in Doberman Pinschers
    Brooks, MB
    Erb, HN
    Foureman, PA
    Ray, K
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2001, 62 (03) : 364 - 369
  • [49] Factor VII-Von willebrand factor ratio in healthy controls and in heterozygous carriers of VWF null alleles and von Willebrand disease type 2N mutations
    Eikenboom, JCJ
    Castaman, G
    Kamphuisen, PW
    Bertina, RM
    THROMBOSIS AND HAEMOSTASIS, 1999, : 686 - 686
  • [50] A commercial elisa method for identifying type 2N von Willebrand disease patients and carriers
    Casonato, A.
    Pontara, E.
    Sartorello, F.
    Cattini, M. G.
    Daidone, V
    Casonato, A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 946 - 946
12345